Catania, Italy

Sebastiano Mangiafico

This inventor holds 1 USPTO granted patent and 5 EPO patents. Top assignee: For Health Pharma S.r.l.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sebastiano Mangiafico. Retrieved from https://idiyas.com/inventor/sebastiano-mangiafico

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Sebastiano Mangiafico

Introduction

Sebastiano Mangiafico is an accomplished inventor based in Catania, Italy. He has made significant contributions to the field of ophthalmology through his innovative formulations. His work focuses on enhancing the stability and effectiveness of ophthalmic compositions.

Latest Patents

Sebastiano holds a patent for a unique formulation that includes tropicamide, at least one cyclodextrin at concentrations of less than 2.5%, and at least one surfactant at concentrations of less than 2.5%. This composition is notable for its physical stability at neutral pH, making it a valuable advancement in ophthalmic treatments. He has 1 patent to his name.

Career Highlights

Throughout his career, Sebastiano has worked with notable companies such as For Health Pharma S.r.l. and Medivis S.r.l. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical industry.

Collaborations

Sebastiano has collaborated with talented individuals in his field, including Danilo Aleo and Sergio Mangiafico. These partnerships have contributed to the success of his projects and the advancement of ophthalmic formulations.

Conclusion

Sebastiano Mangiafico's contributions to ophthalmology through his innovative formulations demonstrate his commitment to improving patient care. His work continues to influence the field and inspire future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…